Location History:
- Little Rock, AR (US) (2002 - 2010)
- Brookline, MA (US) (2015)
- Boston, MA (US) (2020 - 2024)
Company Filing History:
3 out of 836 
1 out of 1 
1 out of 747 
Years Active: 2002-2024
Title: Thomas Dag Horn: Innovator in Immunotherapy
Introduction
Thomas Dag Horn is a notable inventor based in Boston, MA (US), recognized for his contributions to the field of immunotherapy. With a total of 5 patents, he has made significant strides in developing methods to treat viral and fungal infections.
Latest Patents
Among his latest patents, Horn has introduced innovative approaches such as topical immunosensitizers to treat viral and fungal infections. This method involves applying a topical immunosensitizer to the skin of individuals infected with a virus or fungus, aiming to enhance their immune response. Additionally, he has developed methods to improve anti-viral and anti-fungal immunity, including increasing PBMC interferon gamma expression in response to immune stimuli. Another significant patent focuses on a non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection. This method entails locally administering a substance that induces a delayed-type hypersensitivity response at the site of an HSV lesion during outbreaks.
Career Highlights
Throughout his career, Thomas Dag Horn has worked with esteemed organizations, including the University of Arkansas and Squarex Pharmaceutical Corporation. His work has been pivotal in advancing therapeutic strategies for infectious diseases.
Collaborations
Horn has collaborated with notable individuals in his field, including Sandra Marchese Johnson and Hugh McTavish. Their combined expertise has contributed to the development of innovative treatments.
Conclusion
Thomas Dag Horn's work in immunotherapy exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to improving health outcomes for individuals affected by viral and fungal infections.